Silhouette

David Radin

Biostrategies, LC

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Improving MPS I ERT Efficacy through Lectin-Mediated Delivery
Biostrategies, LC
Principal Investigator
HHS 2 $1.24MM 09/30/17 07/31/18
Enzyme replacement therapy for GM1 gangliosidosis lysosomal rare disease
Biostrategies, LC
Principal Investigator
HHS 2 $1.37MM 09/15/17 08/31/18
Enzyme Replacement Therapeutics for Rare Childhood Genetic Diseases: An ERT Delivery System that ...
Biostrategies, LC
Principal Investigator
HHS 1 $225K 07/06/16 06/30/17
Enzyme replacement therapy for Sanfilippo A lysosomal rare disease
Biostrategies, LC
Principal Investigator
HHS 2 $659K 07/01/16 06/30/17
Enzyme replacement therapy for Sanfilippo A lysosomal rare disease
Biostrategies, LC
Principal Investigator
HHS 2 $832K 07/15/15 06/30/16
Improving MPS I ERT Efficacy through Lectin-Mediated Delivery
Biostrategies, LC
Principal Investigator
HHS 1 $186K 07/01/15 06/30/16
Enzyme Replacement Therapy for GM1 Gangliosidosis Lysosomal Rare Disease
Biostrategies, LC
Principal Investigator
HHS 1 $225K 07/01/14 06/30/15
Improving MPS I ERT Efficacy through Lectin-Mediated Delivery
Biostrategies, LC
Principal Investigator
HHS 1 $458K 07/01/14 06/30/15
Targeted Enzyme Replacement Therapy for Rare Forms of Osteogenesis Imperfecta
Biostrategies, LC
Principal Investigator
HHS 1 $223K 06/01/14 05/31/15
Enzyme Replacement Therapy for Sanfilippo A Lysosomal Rare Disease
Biostrategies, LC
Principal Investigator
HHS 1 $286K 04/15/13 03/31/14
A Novel Plant Cell Bio-Production Platform for Therapeutic Proteins
Biostrategies, LC
Principal Investigator
HHS 1 $151K 06/15/10 05/31/13